Disclosure of Share-based Compensation Arrangements by Share-based Payment Award |
The following table contains information about both plans as of December 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards Reserved for Issuance |
|
Awards Exercised |
|
Awards Outstanding |
|
Awards Available for Grant |
|
|
|
|
|
|
|
|
2016 Equity Incentive Plan |
999,906 |
|
|
— |
|
|
499,953 |
|
|
499,953 |
|
2018 Equity Incentive Plan |
29,920,933 |
|
|
4,022,133 |
|
|
13,326,509 |
|
|
12,572,291 |
|
2019 Equity Incentive Plan |
61,109,696 |
|
|
34,884 |
|
|
37,617,531 |
|
|
23,457,281 |
|
Stock-Based Compensation Expense
The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except for number of shares or options) For the Year Ended |
|
|
December 31, 2022 |
|
December 31, 2021 |
Type of Award |
|
Number of Shares or Options Granted |
|
Stock-Based Compensation Expense |
|
Number of Shares or Options Granted |
|
Stock- Based Compensation Expense |
|
|
|
|
|
|
|
|
|
Stock Options |
|
1,075,001 |
|
|
$ |
3,659 |
|
|
89,930,019 |
|
|
$ |
2,415 |
|
|
|
|
|
|
|
|
|
|
Stock Grants: |
|
|
|
|
|
|
|
|
Employees (Common Stock) |
|
2,100,000 |
|
|
352 |
|
|
250,000 |
|
|
68 |
|
Directors (Common Stock) |
|
943,128 |
|
|
213 |
|
|
1,917,837 |
|
|
495 |
|
Non–Employee Consultants (Common Stock) |
|
16,906,230 |
|
|
695 |
|
|
4,556,603 |
|
|
1,079 |
|
|
|
|
|
|
|
|
|
|
Total Stock–Based Compensation Expense |
|
|
|
$ |
4,919
|
|
|
|
|
$ |
4,057
|
|
The service period is generally the vesting period. The following weighted-average assumptions were used to calculate stock-based compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
|
2021 |
Expected Term |
5.2 years |
|
5 years |
Volatility |
103.0 |
% |
|
106.7 |
% |
Risk-Free Interest Rate |
0.9 |
% |
|
0.8 |
% |
Dividend Yield |
0 |
% |
|
0 |
% |
|
Share-based Payment Arrangement, Option, Activity |
The following table summarizes the Company’s stock option activity and related information for the years ended December 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted- Average Exercise Price Per Share |
|
Weighted- Average Remaining Contractual Life |
|
Aggregate Intrinsic Value of In- the-Money Options |
|
|
|
|
|
|
|
|
Options Outstanding as of December 31, 2020 |
17,492,830
|
|
|
$ |
0.41 |
|
|
|
|
|
Granted |
88,627,220 |
|
|
$ |
0.23 |
|
|
|
|
|
Exercised |
(3,910,805) |
|
|
$ |
— |
|
|
|
|
|
Forfeited |
(13,547,745) |
|
|
$ |
0.15 |
|
|
|
|
|
Expired |
(410,120) |
|
|
$ |
0.41 |
|
|
|
|
|
Options Outstanding as of December 31, 2021 |
88,251,380
|
|
|
$ |
0.20
|
|
|
|
|
|
Granted |
1,075,001 |
|
|
$ |
0.14 |
|
|
|
|
|
Exercised |
(146,212) |
|
|
$ |
0.07 |
|
|
|
|
|
Forfeited |
(19,365,073) |
|
|
$ |
0.13 |
|
|
|
|
|
Expired |
(16,993,997) |
|
|
$ |
0.17 |
|
|
|
|
|
Options Outstanding as of December 31, 2022 |
52,821,099
|
|
|
$ |
0.23
|
|
|
7.9 years |
|
$ |
2,846
|
|
Options Exercisable as of December 31, 2022 |
36,825,119
|
|
|
$ |
0.27
|
|
|
7.6 years |
|
$ |
—
|
|
|